Clinic Roundup

March 2013
BioWorld Today;3/26/2013, Vol. 24 Issue 59, p4
This section offers news briefs concerning drug clinical trials. Auxilium Pharmaceuticals Inc. reported positive data from the Phase IIa open-label study of Xiaflex therapeutic safety in adhesive capsulitis. OncoSec Medical Inc. posted positive response results from its Phase II clinical trial of ImmunoPulse DNA-based immunotherapy and NeoPulse therapy. Viralytics Ltd. presented results of its CALM Phase II trial at the HemOnc Today Melanoma and Cutaneous Malignancies meeting in New York City.


Related Articles

  • Phase Report.  // Applied Clinical Trials;Jul2007, Vol. 16 Issue 7, p16 

    The article reports on development related to clinical trials. An increased response to therapy for tumor eradication has been shown in a new Phase III study of Herceptin marketed by Hoffman-La Roche Inc. Cytos Biotechnology has licensed its Phase II nicotine addiction vaccine to Novartis for...

  • Clinic Roundup.  // BioWorld Today;3/10/2011, Vol. 22 Issue 47, p2 

    This section offers news briefs related to biotechnology firms as of March 2011, including the submission of an investigational new drug application to the U.S. Food and Drug Administration (FDA) by Adamis Pharmaceuticals Corp., the status of Auxilium Pharmaceutical Incorporated's study of...

  • CLINIC ROUNDUP.  // BioWorld Today;5/23/2007, Vol. 18 Issue 100, p3 

    The article offers news briefs on clinical trials. Improvements in symptoms of decreased libido and erectile dysfunction in hypogonadal men were reported by Auxilium Pharmaceuticals Inc. in a retrospective data reported at an American Urological Association meeting. A phase I-data showing...

  • ASCO ROUNDUP.  // BioWorld Today;6/4/2008, Vol. 19 Issue 108, p6 

    The article reports on the results of Auxilium Pharmaceuticals Inc.'s CORD I and CORD II Phase III trials of Xiaflex in Dupuytren's contracture. The main endpoints were a reduction in the angle of a patient's joint contracture to less than or equal to 5 degrees of normal. Results also showed the...

  • Phase I.  // Applied Clinical Trials;Jul2005, Vol. 14 Issue 7, p18 

    Provides information related to recent phase I clinical trials. Initiation of a trial of oral paclitaxel for advanced cancer by France-based Novagali; Outcome of Chemokine Therapeutics Corp.'s trial of CTCE-0214 for immune-system; Completion of gene transfer procedures in a trial for a...

  • Drug Trials and Older People. Witham, Miles D. // Drugs & Aging;2011, Vol. 28 Issue 8, p679 

    No abstract available.

  • From the Editor's desk. Tyrer, Peter // British Journal of Psychiatry;Mar2010, Vol. 196 Issue 3, p254 

    An introduction to the journal is presented in which the editor discusses reports published within the issue including the importance of attention to methodology in clinical trials, restriction of publication bias to drug trials, and the mental ill-effects of neglect, abuse, and deprivation.

  • National Pharmaceutical Institute answers allegations.  // Life Science Today;Feb2001, Vol. 2 Issue 1, p7 

    Reports on the Hungarian National Pharmaceutical Institute's denial that dangerous drug experiments are being carried out on unsuspecting patients. Rules concerning clinical trials in Hungary; Reasons that make Europe an easier place to find clinical trial patients.

  • ADVANCE-2: Apixaban had favorable risk-benefit profile compared with enoxaparin.  // Hem/Onc Today;8/10/2009, Vol. 10 Issue 15, p23 

    The article discusses the results of a clinical drug trial which revealed the therapeutic use of apixaban for thromboprophylaxis after total knee replacement.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics